Ranitidine
- Generic Name
- Ranitidine
- Brand Names
- Good Sense Acid Reducer, Wal-zan, Zantac
- Drug Type
- Small Molecule
- Chemical Formula
- C13H22N4O3S
- CAS Number
- 66357-35-5
- Unique Ingredient Identifier
- 884KT10YB7
- Background
Ranitidine is a commonly used drug, classified as a histamine H2-receptor antagonist, and belongs to the same drug class as cimetidine and famotidine. This drug helps to prevent and treat gastric-acid associated conditions, including ulcers, because of its ability to decrease gastric acid secretion. Ranitidine is often referred to as Zantac, and is available...
- Indication
This drug is used alone or with concomitant antacids for the following conditions: short-term treatment of active duodenal ulcer, treating gastric acid hypersecretion due to Zollinger-Ellison syndrome, systemic mastocytosis, and other conditions that may pathologically raise gastric acid levels. It also used in the short term treatment of active benign gastr...
- Associated Conditions
- Acid Aspiration Syndrome, Ankylosing Spondylitis (AS), Duodenal Ulcer, Erosive Esophagitis, Gastric Ulcer, Gastric hypersecretion, Gastro-esophageal Reflux Disease (GERD), Healing, Heartburn, Osteoarthritis (OA), Peptic Ulcer Disease, Rheumatoid Arthritis, Stress Ulcers, Zollinger-Ellison Syndrome, Active Duodenal ulcer, Benign gastric ulcer healing, Benign gastric ulcers, Duodenal ulcer healing, Post-operative peptic ulcer, Recurrent hemorrhage from bleeding ulcers
- Associated Therapies
- -
GSK advances mRNA flu vaccine into phase III trials
Keynoter Doug Long Sees Fragility, 'Pretty Anemic' Launches As He Looks Ahead to Retirement
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.